We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.79B
AUM Growth
+$618M
Cap. Flow
+$595M
Cap. Flow %
33.32%
Top 10 Hldgs %
16.68%
Holding
4,499
New
1,229
Increased
1,153
Reduced
1,264
Closed
790

Sector Composition

Rank Sector Weight
1 Technology 13.59%
2 Financials 10.04%
3 Healthcare 8.35%
4 Industrials 7.34%
5 Consumer Discretionary 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MBFI
2451
DELISTED
MB Financial Corp
MBFI
$20K ﹤0.01%
427
-18,051
-98% -$826K
STDY
2452
DELISTED
SteadyMed Ltd
STDY
$20K ﹤0.01%
+4,361
New +$17.8K
KLDX
2453
DELISTED
KLONDEX MINES LTD
KLDX
$20K ﹤0.01%
8,855
-5,466
-38% -$13.3K
PDLI
2454
DELISTED
PDL BioPharma, Inc.
PDLI
$20K ﹤0.01%
8,570
+1,295
+18% +$3.62K
ASC icon
2455
Ardmore Shipping
ASC
$683M
$19K ﹤0.01%
+2,295
New +$18.4K
BGR icon
2456
BlackRock Energy and Resources Trust
BGR
$405M
$19K ﹤0.01%
+1,233
New +$18.1K
CMT icon
2457
Core Molding Technologies
CMT
$234M
$19K ﹤0.01%
+1,300
New +$20K
CWCO icon
2458
Consolidated Water Co
CWCO
$488M
$19K ﹤0.01%
+1,404
New +$18.7K
DENN
2459
DELISTED
Denny's
DENN
$19K ﹤0.01%
1,203
-531
-31% -$8.44K
DTD icon
2460
WisdomTree US Total Dividend Fund
DTD
$1.69B
$19K ﹤0.01%
424
EDC icon
2461
Direxion Daily MSCI Emerging Markets Bull 3X ETF
EDC
$161M
$19K ﹤0.01%
208
+110
+112% +$12.2K
EWY icon
2462
iShares MSCI South Korea ETF
EWY
$24.1B
$19K ﹤0.01%
276
-8,861
-97% -$647K
FMAO icon
2463
Farmers & Merchants Bancorp
FMAO
$481M
$19K ﹤0.01%
+473
New +$20K
GVA icon
2464
Granite Construction
GVA
$5.62B
$19K ﹤0.01%
342
-2,130
-86% -$120K
JAZZ icon
2465
Jazz Pharmaceuticals
JAZZ
$16.7B
$19K ﹤0.01%
+113
New +$18.5K
LKFN icon
2466
Lakeland Financial Corp
LKFN
$1.53B
$19K ﹤0.01%
398
-2,282
-85% -$111K
LOOP icon
2467
Loop Industries
LOOP
$32.9M
$19K ﹤0.01%
1,705
+1,242
+268% +$15.2K
MED icon
2468
Medifast
MED
$141M
$19K ﹤0.01%
+117
New +$15K
OCUL icon
2469
Ocular Therapeutix
OCUL
$2.02B
$19K ﹤0.01%
2,839
+2,262
+392% +$15.5K
PBHC icon
2470
Pathfinder Bancorp
PBHC
$104M
$19K ﹤0.01%
1,169
+1,008
+626% +$15.9K
PXLW icon
2471
Pixelworks
PXLW
$41.6M
$19K ﹤0.01%
428
+112
+35% +$5.49K
RM icon
2472
Regional Management Corp
RM
$303M
$19K ﹤0.01%
+551
New +$19.3K
SPXL icon
2473
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$7.42B
$19K ﹤0.01%
436
-12,933
-97% -$567K
SRI icon
2474
Stoneridge
SRI
$213M
$19K ﹤0.01%
+550
New +$16.7K
VRDN icon
2475
Viridian Therapeutics
VRDN
$2.67B
$19K ﹤0.01%
201
-644
-76% -$68.1K

Similar funds

Tower Research Capital (TRC)'s Q2 2018 Portfolio in Review

As of Q2 2018, Tower Research Capital (TRC) held 4,499 positions worth $1.79B, up 53% from $1.17B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Tower Research Capital (TRC) deployed $595M of net new capital in Q2 2018, opening 1,229 new positions and adding to 1,153 existing holdings. Its largest new stake was JPMorgan Chase: 180,678 shares worth $18.8M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 4.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $31.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2018 buy was JPMorgan Chase: 180,678 shares worth $18.8M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2018, an estimated $51.7M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2018 reduction was iShares MSCI EAFE ETF, cutting an estimated $31.8M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Dow Jones REIT ETF in Q2 2018, selling an estimated $6.85M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 17% of its $1.79B portfolio in Q2 2018.
  • Tower Research Capital (TRC) opened 1,229 new positions and closed 790 in Q2 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 53% quarter-over-quarter to $1.79B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2018, filed 15 Aug 2018.